|
Volumn 40, Issue 3, 2008, Pages 657-661
|
Clinical implications of introducing a new PSA assay
|
Author keywords
Assay; Prostate cancer; Prostate specific antigen
|
Indexed keywords
PROSTATE SPECIFIC ANTIGEN;
ADULT;
ANTIGEN DETECTION;
ARTICLE;
AWARENESS;
BLOOD SAMPLING;
CANCER RADIOTHERAPY;
CANCER STAGING;
CONTROLLED STUDY;
CORRELATION COEFFICIENT;
DIAGNOSTIC ACCURACY;
FOLLOW UP;
GLEASON SCORE;
HUMAN;
IMMUNOASSAY;
INTERMETHOD COMPARISON;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL DECISION MAKING;
PATIENT MONITORING;
POSTOPERATIVE PERIOD;
PREOPERATIVE EVALUATION;
PROSTATE BIOPSY;
PROSTATE CANCER;
PROSTATECTOMY;
REPRODUCIBILITY;
HUMANS;
LINEAR MODELS;
MALE;
PROSPECTIVE STUDIES;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
REPRODUCIBILITY OF RESULTS;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 48549107057
PISSN: 03011623
EISSN: None
Source Type: Journal
DOI: 10.1007/s11255-007-9330-7 Document Type: Article |
Times cited : (4)
|
References (5)
|